Roche to start new trial of AC Immune drug against Alzheimer's

ZURICH, Feb 28 (Reuters) - Roche is starting a

second late-stage trial of investigational Alzheimer's drug

crenezumab that it is developing with Swiss biotech AC Immune

, shrugging off failures of similar drugs against the

memory-robbing disease.

Read more